The results of the present study from 121 preterm infants aged 28 - 36 weeks who experienced respiratory distress using NCPAP showed that 36 neonates had respiratory failure (29.7%) with an estimated time of respiratory failure of 60.5 hours. A study by Maria reported that among 57 preterm neonates less than 36 weeks of gestation with respiratory distress receiving NCPAP, 26.3% experienced NCPAP failure in the first 72 hours (
18). Another cohort study showed that among 150 preterm neonates with less than 37 weeks of gestation with respiratory distress receiving NCPAP, 37.8% experienced NCPAP failure in the first 72 hours (
16). Another study also demonstrated that among 174 preterm neonates of less than 34 weeks of gestation with respiratory distress receiving NCPAP, 37.4% experienced NCPAP failure in the first 72 hours (
19). In the present study, the frequency of CPAP failure at 28 - 32 and 33 - 34 weeks of gestation was 64% and 42%, respectively.
Gestational age of 28 - 32 weeks experienced the most respiratory distress and respiratory failure, with a survival rate of 54.5%. This finding is in line with study findings by Gutvirtz et al., which showed that gestational age under 32 weeks increased mortality and morbidity but did not report the age at which death occurred (
20).
The most common causes of respiratory distress observed in this study were respiratory distress syndrome (85%) and transient tachypnea in newborns (14%). Neonatal respiratory distress syndrome (RDS) occurs from a deficiency of surfactant due to either inadequate surfactant production or surfactant inactivation in the context of immature lungs. Prematurity affects both these factors, thereby directly contributing to RDS. Respiratory distress syndrome causes hyaline membrane formation in the lungs, making the lungs stiff and poor for gaseous exchange. This disease, in the first 3 days of life, increases the work of breathing and hypoxia, and if not addressed, it causes respiratory failure and/or death (
2,
21).
The incidence of RDS is inversely related to the gestational age. The mainstay in the management of RDS involves early continuous positive airway pressure (CPAP), surfactant replacement, and mechanical ventilation if needed. Continuous positive airway pressure provides a distending pressure, which results in better lung volumes and improvement of ventilation‐perfusion mismatch. It might have other benefits, including stretching of the Hering-Breuer reflex, which might improve respiratory drive and result in more regular breathing (
22,
23).
Transient tachypnea of the newborn (TTN) was originally described as the clinical manifestation of delayed clearance of fetal lung fluid. Transient tachypnea of the newborn is characterized by a respiratory rate greater than 60 breaths per minute (tachypnea) and signs of respiratory distress (grunting, flaring of nostrils, and intercostal retraction). The clinical features typically appear immediately after birth or within the first two hours of life in term and late preterm newborns. The incidence of TTN can reach up to 13% in late preterm and among term infants delivered by elective cesarean section. Common risk factors for TTN include delivery before 39 weeks of gestational age, precipitous delivery, fetal distress, maternal sedation, and gestational diabetes. The management of TTN is supportive, and standard care with supplemental oxygen might be sufficient. However, non‐invasive respiratory support might be administered to reduce respiratory distress during TTN (
24). Continuous positive airway pressure as one of the management techniques for TTN might improve functional residual capacity and facilitate fluid reabsorption. It also guarantees an early and adequate alveolar opening. This might, in turn, improve the work of breathing and gas exchange (
25).
According to the results of Cox regression analysis, it was determined that at the age of 2, 6, 12, and 24 hours, a Downes score higher by one point had an increased risk of respiratory failure within 72 hours. This condition is further increased when a one-point higher Downes score is observed at a greater age in hours.
Researchers took the Downes score of 4 according to the guidelines used by PONED and USAID in Indonesia as the cut-off for the definition of moderate respiratory distress that requires breathing assistance. Based on the criteria used by USAID Indonesia, scores of 4 - 7 were categorized as having respiratory distress, and based on PONED, scores of 4 - 5 were categorized as moderate respiratory distress (
14,
15). According to the criteria used, the threat of respiratory failure was considered a Downes score > 7, and in previous studies, a Downes score of 4 was used to determine the indication for starting respiratory support NCPAP. A study by Dagar in 2015 showed that a Downes score of 4 had a sensitivity of 59%, a specificity of 77.39%, and a PPV of 50% in predicting the use of mechanical ventilation with an OR of 4.94 (95% CI: 2.35 - 10.39) and a Downes score 3 with an oxygen saturation of 89% at the start of the examination related to the respiratory support need in the first 72 hours (
17).
Monitoring Downes score in 24 hours in this study showed that a Downes score of 4 in neonates with 28 - 36 weeks of gestation who experienced respiratory distress with NCPAP more and more quickly experienced respiratory failure. Survival analysis with the Kaplan-Meier test showed that neonates 28 - 36 weeks of gestation with Downes scores start from 4 (>4), having a lower survival rate. Therefore, neonates with a Downes score >4 were found to experience more respiratory failure. Respiratory failure occurs more rapidly when a Downes score of 4 is observed at a greater age in hours.
Using Cox regression analysis showed the relationship of Downes score 4 with the risk of respiratory failure in the first 72 hours in neonates of 28 - 36 weeks gestation with respiratory distress and using NCPAP. In this case, it can be said that at the age of 2, 6, 12, and 24 hours under monitoring, a Downes score of ≥ 4 will increase the risk of respiratory failure 3.26 times (P = 0.030), 2.44 times (P = 0.014), 3.8 times (P < 0.001), and 6.93 times (P < 1.001), respectively, which is statistically significant. Cox regression analysis showed that higher Downes scores, increased Downes scores, and Downes scores ≥ 4 at birth were not statistically significant (P = 0.702) associated with the incidence of respiratory failure. This might be due to the neonatal adaptation process and the variation in lung compliance in the first 2 hours. Pulmonary compliance at the beginning of birth is low; then, with the onset of breathing and lung fluid clearance, it will increase lung compliance in the first 6 hours (
26).
This study showed an association between an increase in Downes score with the time of occurrence and the risk of respiratory failure in neonates of 28 - 36 weeks who experienced respiratory distress and used NCPAP. The limitation of this study is that not all confounding factors can be included in this survival analysis.